Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3967/bes2019.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of two polymerase chain reaction assays, DaAn Gene (DaAn Gene 2019-ncov) and Cepheid (Cepheid Xpert Xpress SARS-CoV-2) for Delta and Omicron variants of SARS-CoV-2 detection in Yaoundé, Cameroon.
J Public Health Afr
July 2025
Centre for Research on Emerging and Re-emerging Diseases (CREMER), Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé, Cameroon.
Background: New severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may affect diagnostic test accuracy.
Aim: To evaluate the performance of two reverse transcription-polymerase chain reaction (RT-PCR) assays, DaAn Gene and Cepheid, for detecting Delta and Omicron variants.
Setting: Nasopharyngeal samples were collected in Yaoundé, Cameroon, between October 2021 and December 2022.
Comparison of Xpert® MTB/RIF and Xpert® MTB/RIF Ultra in pediatric pulmonary tuberculosis diagnosis.
J Trop Pediatr
August 2025
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
The World Health Organization (WHO) recommends Xpert® MTB/RIF (Xpert) and its advanced version, Xpert® MTB/RIF Ultra (Xpert Ultra), as first-line diagnostic tests for detecting pulmonary tuberculosis (PTB) and rifampicin resistance in children suspected of having the disease. Respiratory specimens (gastric lavage/bronchoalveolar lavage/sputum/endotracheal aspirate) obtained from 116 children with presumptive PTB were simultaneously processed using liquid medium culture, Xpert assay, and Xpert Ultra assay. Among the specimens from 116 children, six were excluded due to culture contamination (n = 5) or error in Xpert Ultra results (n = 1).
View Article and Find Full Text PDFDiagnostic performance of Xpert MTB/RIF in lymph node tuberculosis in a general hospital.
J Thorac Dis
June 2025
Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Background: In general hospitals, tuberculosis (TB) is an important infectious cause of lymphadenopathy, but its etiological diagnosis rate is very low. This study aimed to determine the performance of Xpert MTB/RIF(Xpert) in differentiate tuberculous lymphadenopathy from other causes.
Methods: A retrospective pairing study was carried out from August 2015 to July 2024.
Correlation of Trace detection in Gene Xpert MTB/RIF ultra with MGIT TB culture in a high TB-endemic Country.
Tuberculosis (Edinb)
September 2025
Department of Microbiology, P.D.Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India. Electronic address:
Background: The Gene Xpert MTB/RIF Ultra is a Cartridge-Based Nucleic Acid Amplification Test (CBNAAT) for rapid detection of Mycobacterium tuberculosis (MTB) and rifampicin (RIF) drug susceptibility testing (DST) pattern.
Objective: 1)To compare the culture results of samples detected as a Trace on Gene Xpert MTB/RIF Ultra with MTB growth in liquid culture. 2) To compare the rifampicin indeterminate results from Gene Xpert MTB/RIF Ultra with MGIT RIF DST pattern.
Targeted next-generation sequencing: a promising approach for detection and drug resistance when applied in paucibacillary clinical samples.
Microbiol Spectr
July 2025
Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Tuberculosis (TB) returns to be the leading infectious killer globally after coronavirus disease 2019. The World Health Organization (WHO) formally included targeted next-generation sequencing (tNGS) in its list of recommendations for (MTB) and drug resistance (DR). In this study, we explored the application of various clinical sample types for TB diagnosis and DR profiles.
View Article and Find Full Text PDF